Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease - Poll - MDSpire

Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease

At ARVO 2026, Ikarovec presented 4 posters showcasing its bicistronic platform that combines neuroprotection and complement modulation.

  • By

  • Katie Binley, PhD

  • May 1, 2026

  • 3 min

Share

Original Source(s)

Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease

  • by Katie Binley, PhD

  • May 1, 2026

Related Content

Research progress on intraocular lens power calculation in cataract patients with prior radial keratotomy

Endogenous Endophthalmitis and Missed Diagnoses

Retrospective study describes how endogenous endophthalmitis often presents without systemic symptoms

  • July 21, 2026

  • 3 min
Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.